Improving SH3 domain ligand selectivity using a non-natural scaffold
- PMID: 10903934
- DOI: 10.1016/s1074-5521(00)00130-7
Improving SH3 domain ligand selectivity using a non-natural scaffold
Abstract
Background: Src homology 3 (SH3) domains bind sequences bearing the consensus motif PxxP (where P is proline and x is any amino acid), wherein domain specificity is mediated largely by sequences flanking the PxxP core. This specificity is limited, however, as most SH3 domains show high ligand cross-reactivity. We have recently shown that diverse N-substituted residues (peptoids) can replace the prolines in the PxxP motif, yielding a new source of ligand specificity.
Results: We have tested the effects of combining multiple peptoid substitutions with specific flanking sequences on ligand affinity and specificity. We show that by varying these different elements, a ligand can be selectively tuned to target a single SH3 domain in a test set. In addition, we show that by making multiple peptoid substitutions, high-affinity ligands can be generated that completely lack the canonical PxxP motif. The resulting ligands can potently disrupt natural SH3-mediated interactions.
Conclusions: Peptide-peptoid hybrid scaffolds yield SH3 ligands with markedly improved domain selectivity, overcoming one of the principal challenges in designing inhibitors against these domains. These compounds represent important leads in the search for orthogonal inhibitors of SH3 domains, and can serve as tools for the dissection of complex signaling pathways.
Similar articles
-
Targeting the SH3 domain of human osteoclast-stimulating factor with rationally designed peptoid inhibitors.J Pept Sci. 2016 Aug;22(8):533-9. doi: 10.1002/psc.2901. J Pept Sci. 2016. PMID: 27443979
-
Exploring the systematic effect of N-substituted PxxP motifs on peptoid affinity to ARHGEF5/TIM SH3 domain and its relationship with ARHGEF5/TIM activation.Proteins. 2019 Nov;87(11):979-991. doi: 10.1002/prot.25760. Epub 2019 Jun 28. Proteins. 2019. PMID: 31197859
-
Diverse recognition of non-PxxP peptide ligands by the SH3 domains from p67(phox), Grb2 and Pex13p.EMBO J. 2002 Aug 15;21(16):4268-76. doi: 10.1093/emboj/cdf428. EMBO J. 2002. PMID: 12169629 Free PMC article.
-
The SH3 domain--a family of versatile peptide- and protein-recognition module.Front Biosci. 2008 May 1;13:4938-52. doi: 10.2741/3053. Front Biosci. 2008. PMID: 18508559 Review.
-
SH3 domain ligand binding: What's the consensus and where's the specificity?FEBS Lett. 2012 Aug 14;586(17):2609-14. doi: 10.1016/j.febslet.2012.04.042. Epub 2012 May 2. FEBS Lett. 2012. PMID: 22710157 Review.
Cited by
-
Allosteric regulators selectively prevent Ca2+-feedback of CaV and NaV channels.Elife. 2018 Sep 10;7:e35222. doi: 10.7554/eLife.35222. Elife. 2018. PMID: 30198845 Free PMC article.
-
Exploring the druggability of the UEV domain of human TSG101 in search for broad-spectrum antivirals.Protein Sci. 2025 Jan;34(1):e70005. doi: 10.1002/pro.70005. Protein Sci. 2025. PMID: 39724449 Free PMC article.
-
A readily applicable strategy to convert peptides to peptoid-based therapeutics.PLoS One. 2013;8(3):e58874. doi: 10.1371/journal.pone.0058874. Epub 2013 Mar 21. PLoS One. 2013. PMID: 23555603 Free PMC article.
-
Synthetic ligands discovered by in vitro selection.J Am Chem Soc. 2007 Oct 31;129(43):13137-43. doi: 10.1021/ja073993a. Epub 2007 Oct 6. J Am Chem Soc. 2007. PMID: 17918937 Free PMC article.
-
New strategies for the design of folded peptoids revealed by a survey of noncovalent interactions in model systems.J Am Chem Soc. 2009 Nov 18;131(45):16555-67. doi: 10.1021/ja907184g. J Am Chem Soc. 2009. PMID: 19860427 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous